US 6673559
Met proto-oncogene and a method for predicting breast cancer progression
expired A61KA61K38/193
Quick answer
US patent 6673559 (Met proto-oncogene and a method for predicting breast cancer progression) held by The United States of America as Represented by the Government of the Department of Health and Human Services expires Mon Jan 01 2024 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.
Key facts
- Applicant
- The United States of America as Represented by the Government of the Department of Health and Human Services
- Grant date
- Tue Jan 06 2004 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 01 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 4
- CPC classes
- A61K, A61K38/193